惠泰医疗2025年业绩快报：营收净利双增超20%，PFA产品成增长引擎

Core Viewpoint - Shenzhen Huitai Medical Equipment Co., Ltd. reported a strong performance for the fiscal year 2025, with significant growth in revenue and net profit driven by market expansion and product promotion [1] Financial Performance - The company achieved total operating revenue of approximately 2.584 billion yuan, representing a year-on-year increase of 25.08% [1] - The net profit attributable to shareholders was approximately 821 million yuan, reflecting a year-on-year growth of 21.91% [1] - The net profit after deducting non-recurring gains and losses was about 791 million yuan, with a year-on-year increase of 23.00% [1] Operational Highlights - The company's steady growth is attributed to continuous market development and channel deepening, which enhanced product coverage and hospital admission rates [1] - Focus on core products such as PFA (Pulsed Field Ablation) has driven market promotion and R&D iterations, leading to coordinated growth in revenue and profit [1] Asset and Equity Growth - As of the end of the reporting period, total assets were approximately 3.652 billion yuan, an increase of 22.52% compared to the beginning of the period [1] - The equity attributable to shareholders was about 3.089 billion yuan, up 22.74% from the beginning of the period [1] - The company's share capital increased to approximately 141 million shares due to the implementation of a capital reserve conversion plan [1]